U.S. Markets closed

Intersect ENT reports 4Q loss

MENLO PARK, Calif. (AP) _ Intersect ENT Inc. (XENT) on Tuesday reported a loss of $4.8 million in its fourth quarter.

The Menlo Park, California-based company said it had a loss of 17 cents per share.

The results beat Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 20 cents per share.

The maker of absorbable nasal implants posted revenue of $24.2 million in the period, also beating Street forecasts. Four analysts surveyed by Zacks expected $23.7 million.

For the year, the company reported that its loss narrowed to $25.2 million, or 89 cents per share. Revenue was reported as $78.7 million.

For the current quarter ending in April, Intersect ENT said it expects revenue in the range of $19 million to $19.5 million.

The company expects full-year revenue in the range of $87 million to $89 million.

Intersect ENT shares have risen 12 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $13.60, a drop of 25 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XENT at https://www.zacks.com/ap/XENT


Keywords: Intersect ENT, Earnings Report